We are live on ! Find out more
1IA

1834 Investment Advisors Portfolio holdings

AUM $883M
1-Year Est. Return 23.82%
This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+23.82%
3 Year Est. Return
+61.82%
5 Year Est. Return
+69.87%
10 Year Est. Return
+204.78%
AUM
$652M
AUM Growth
-$36.7M
Cap. Flow
-$80.2M
Cap. Flow %
-12.3%
Top 10 Hldgs %
30.85%
Holding
511
New
49
Increased
76
Reduced
151
Closed
54

Sector Composition

Rank Sector Weight
1 Technology 8.34%
2 Healthcare 8.25%
3 Industrials 5.43%
4 Communication Services 5.04%
5 Financials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY.RT
351
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$15K ﹤0.01%
+5,050
New +$13.1K
GEN icon
352
Gen Digital
GEN
$17.5B
$14K ﹤0.01%
530
MRVL icon
353
Marvell Technology
MRVL
$196B
$14K ﹤0.01%
544
-4,500
-89% -$114K
MTG icon
354
MGIC Investment
MTG
$6.25B
$14K ﹤0.01%
1,000
SBUX icon
355
Starbucks
SBUX
$120B
$14K ﹤0.01%
155
SCHD icon
356
Schwab US Dividend Equity ETF
SCHD
$105B
$14K ﹤0.01%
705
VDC icon
357
Vanguard Consumer Staples ETF
VDC
$7.99B
$14K ﹤0.01%
89
AMRN
358
Amarin Corp
AMRN
$303M
$13K ﹤0.01%
30
HPE icon
359
Hewlett Packard
HPE
$70.5B
$13K ﹤0.01%
822
IEI icon
360
iShares 3-7 Year Treasury Bond ETF
IEI
$17.8B
$13K ﹤0.01%
104
+1
+1% +$126
XRT icon
361
State Street SPDR S&P Retail ETF
XRT
$327M
$13K ﹤0.01%
273
+163
+148% +$7.17K
MDP
362
DELISTED
Meredith Corporation
MDP
$13K ﹤0.01%
+385
New +$13.7K
BHF icon
363
Brighthouse Financial
BHF
$3.5B
$12K ﹤0.01%
300
-250
-45% -$9.84K
CRSP icon
364
CRISPR Therapeutics
CRSP
$5.17B
$12K ﹤0.01%
200
IBB icon
365
iShares Biotechnology ETF
IBB
$9.77B
$12K ﹤0.01%
+99
New +$11K
PIM
366
Franklin Master Intermediate Income Trust
PIM
$151M
$12K ﹤0.01%
2,500
RSPG icon
367
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$546M
$12K ﹤0.01%
248
+66
+36% +$2.93K
VSH icon
368
Vishay Intertechnology
VSH
$5.43B
$12K ﹤0.01%
563
WY icon
369
Weyerhaeuser
WY
$18.4B
$12K ﹤0.01%
400
-1,200
-75% -$34.8K
XPH icon
370
State Street SPDR S&P Pharmaceuticals ETF
XPH
$508M
$12K ﹤0.01%
+256
New +$10.1K
FLG
371
Flagstar Bank National Association
FLG
$5.82B
$12K ﹤0.01%
+332
New +$12.3K
EXC icon
372
Exelon
EXC
$47B
$11K ﹤0.01%
+351
New +$11.4K
NUV icon
373
Nuveen Municipal Value Fund
NUV
$1.91B
$11K ﹤0.01%
1,000
VDE icon
374
Vanguard Energy ETF
VDE
$9.74B
$11K ﹤0.01%
+138
New +$10.7K
WM icon
375
Waste Management
WM
$91B
$11K ﹤0.01%
100

Similar funds

1834 Investment Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, 1834 Investment Advisors held 511 positions worth $652M, down 5.3% from $689M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

1834 Investment Advisors withdrew a net $80.2M in Q4 2019, closing 54 positions and reducing 151 holdings. Its most notable exit was ProShares Ultra S&P500, an estimated $976K position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.1% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, 1834 Investment Advisors opened a new position in Royal Caribbean worth $1.63M.

  • 1834 Investment Advisors's largest Q4 2019 buy was Royal Caribbean: 12,198 shares worth $1.63M.
  • 1834 Investment Advisors added most to JPMorgan Ultra-Short Income ETF in Q4 2019, an estimated $7.83M increase.
  • 1834 Investment Advisors's biggest Q4 2019 reduction was Kohl's, cutting an estimated $8.56M.
  • 1834 Investment Advisors fully exited ProShares Ultra S&P500 in Q4 2019, selling an estimated $976K.
  • 1834 Investment Advisors's ten largest holdings make up 31% of its $652M portfolio in Q4 2019.
  • 1834 Investment Advisors opened 49 new positions and closed 54 in Q4 2019.
  • 1834 Investment Advisors's portfolio value fell 5.3% quarter-over-quarter to $652M.

Based on 1834 Investment Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.